Allergan's sales of eye care pharmaceuticals rose by 6.6 percent year-on-year to $603.4 million in the fourth quarter of 2010. At constant currency rates, turnover was up by 7.4 percent. The company's overall revenues rose by 6.9 percent, or by 7.4 percent on a currency-neutral basis, and reached $1.29 billion. ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.